<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00977821</url>
  </required_header>
  <id_info>
    <org_study_id>0901-F-054-CS</org_study_id>
    <nct_id>NCT00977821</nct_id>
  </id_info>
  <brief_title>Embryo Developmental Capacity After Egg Banking in an Ovum Donation Program</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Valenciano de Infertilidad, IVI VALENCIA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Valenciano de Infertilidad, IVI VALENCIA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For an efficient &quot;egg banking&quot; system, an equally efficient cryopreservation strategy that
      ensures the viability of the oocytes is required. Very recently, improved and new methods are
      yielding satisfactory results. In particular, vitrification is providing excellent results
      for both survival and clinical outcomes. However, to evaluate the over all out come there are
      other parameters to be considered. In this sense, capacity development of embryos generated
      after oocyte vitrification is a major factor when assessing the viability of vitrified
      oocytes. Accordingly, the evaluation of the capacity of vitrified oocytes to reach the
      blastocyst stage will be highly valuable to fully assess the effectiveness of the &quot;egg
      banking&quot; and its contribution to ovum donation programs.

      The aim of this study is to evaluate the developmental capacity of vitrified oocytes by their
      ability to reach the blastocyst stage. The study includes oocyte donation cycles conducted
      with vitrified versus fresh oocytes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean outcome measures will be survival, fertilization and blastocyst rates and clinical outcome.</measure>
    <time_frame>10 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">625</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>fresh</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Embryo transfer with fresh oocytes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Frozen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Embryo transfer with vitrified oocytes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IVF</intervention_name>
    <arm_group_label>fresh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oocyte Vitrification</intervention_name>
    <arm_group_label>Frozen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-35 year old

          -  Normal response (8-15 follicles) to long protocol of ovarian stimulation with hCG

          -  Donors with normal menstrual cycles (21-35 day duration)

          -  Donors with BMI between 18-25 Kg/m2

        Exclusion Criteria:

          -  Donors with two or more previous miscarriages

          -  Polycystic ovary syndrome

          -  Donors with antecedents of poor embrionary quality not attributed to masculine factor

          -  Donors with drop of estradiol of more than 10% or estradiol plateau.

          -  Donors with a high response&gt;20 oocytes and or levels above 3000pg/ml of estradiol the
             day of the administration of chorionic gonadotrophin (hCG)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2009</study_first_submitted>
  <study_first_submitted_qc>September 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2009</study_first_posted>
  <last_update_submitted>April 21, 2015</last_update_submitted>
  <last_update_submitted_qc>April 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Valenciano de Infertilidad, IVI VALENCIA</investigator_affiliation>
    <investigator_full_name>Carlos Simon</investigator_full_name>
    <investigator_title>Dr. Carlos Simon MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

